0.012616
0.000000
0.000000
0.000000
0.012616
0.000000
0.000000
0.000000
0.012616
0.00000
0.00000
0.00000
Yadav, M.K.
Redman, J.E.
Alvarez-Gutierrez, J.M.
Zhang, Y.
Stout, C.D.
Ghadiri, M.R.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
48
90.00
90.00
90.00
79.265
79.265
79.265
C2 H4 O
44.053
ACETYL GROUP
non-polymer
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
44
9723
10.1021/BI050742A
16008357
Structure-Based Engineering of Internal Cavities in Coiled-Coil Peptides
2005
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
114.0
1
2002-10-15
SINGLE WAVELENGTH
M
x-ray
1
1.5418
1.0
1.5418
ROTATING ANODE
RIGAKU RU200
DIMER ASYMMETRIC UNIT OF FOUR HELIX BUNDLE MUTATION LEU26ALA
4030.757
GENERAL CONTROL PROTEIN GCN4
YES
2
syn
polymer
GCN4 LEUCINE ZIPPER, AMINO ACID BIOSYNTHESIS REGULATORY PROTEIN, PLI
no
yes
(ACE)RMKQIEDKLEEILSKLYHIENELARAKKLLGER
XRMKQIEDKLEEILSKLYHIENELARAKKLLGER
A,B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
1
2.5
50
7.00
2.5 M NACL, 100 MM NAAC, 200 MM LI2SO4, PH 4.5
repository
Initial release
Version format compliance
Version format compliance
1
0
2004-10-13
1
1
2011-05-08
1
2
2011-07-13
GCN4 LEUCINE ZIPPER CORE MUTANT P-LI
GCN4 LEUCINE ZIPPER CORE MUTANT P-LI
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
HELIX CAPPING IN THE GCN4 LEUCINE ZIPPER
GCN4 LEUCINE ZIPPER COMPLEXED WITH SPECIFIC ATF/CREB SITE DEOXYRIBONUCLEIC ACID
ATOMIC STRUCTURE OF THE ECTODOMAIN FROM HIV -1 GP41
THE STRUCTURE OF AN HIV-1 SPECIFIC CELL ENTRY INHIBITOR INCOMPLEX WITH THE HIV-1 GP41 TRIMERIC CORE
HUMAN VIMENTIN COIL 2B FRAGMENT LINKED TO GCN4 LEUCINE ZIPPER (Z2B)
CRYSTAL STRUCTURE OF C14LINKMID/IQN17: A CROSS-LINKED INHIBITOR OF HIV-1 ENTRY BOUND TO THE GP41 HYDROPHOBIC POCKET
GLYTM1BZIP: A CHIMERIC PEPTIDE MODEL OF THE N-TERMINUS OF ARAT SHORT ALPHA TROPOMYOSIN WITH THE N-TERMINUS ENCODED BYEXON 1B
COILED COIL TRIMER GCN4-PVLS SER AT BURIED D POSITION
GCN4-PVLT COILED-COIL TRIMER WITH THREONINE AT THE D(12)POSITION
GCN4-PVTL COILED-COIL TRIMER WITH THREONINE AT THE A(16)POSITION
GCN4-PVSL COILED-COIL TRIMER WITH SERINE AT THE A(16)POSITION
CRYSTAL STRUCTURE OF THE C-TERMINAL REGION OF STRIATEDMUSCLE ALPHA-TROPOMYOSIN AT 2.7 ANGSTROM RESOLUTION
PLACEMENT OF THE STRUCTURAL PROTEINS IN SINDBIS VIRUS
CRYSTAL STRUCTURE OF A ZIF23-GCN4 CHIMERA BOUND TO DNA
VISUALIZING AN UNSTABLE COILED COIL: THE CRYSTAL STRUCTUREOF AN N-TERMINAL SEGMENT OF THE SCALLOP MYOSIN ROD
CRYSTAL STRUCTURE OF GCN4-PIQ, A TRIMERIC COILED COIL WITH BURIED POLAR RESIDUES
GCN4-LEUCINE ZIPPER CORE MUTANT AS N16A TRIGONAL AUTOMATICSOLUTION
ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TETRAGONAL AUTOMATIC SOLUTION
ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TRIGONAL FORM
ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TETRAGONAL FORM
GCN4-LEUCINE ZIPPER CORE MUTANT AS N16A COMPLEXED WITH BENZENE
TMZIP: A CHIMERIC PEPTIDE MODEL OF THE N- TERMINUS OF ALPHA TROPOMYOSIN, NMR, 15 STRUCTURES
AN ANTI-PARALLEL FOUR HELIX BUNDLE ( ACETIMIDE MODIFICATION).
AN ANTI-PARALLEL FOUR HELIX BUNDLE.
ABA DOES NOT AFFECT TOPOLOGY OF PLI.
AN ANTI-PARALLEL FOUR HELIX BUNDLE
AN ANTI-PARALLEL FOUR HELIX BUNDLE
AN ANTI-PARALLEL TO PARALLEL SWITCH.
GCN4 (BASIC REGION, LEUCINE ZIPPER) COMPLEX WITH AP-1 DEOXYRIBONUCLEIC ACID
GCN4-LEUCINE ZIPPER CORE MUTANT ASN16ABA IN THE DIMERIC STATE
GCN4-LEUCINE ZIPPER CORE MUTANT ASN16ABA IN THE TRIMERIC STATE
GCN4-LEUCINE ZIPPER CORE MUTANT ASN16LYS IN THE DIMERIC STATE
GCN4-LEUCINE ZIPPER CORE MUTANT ASN16GLN IN THE DIMERIC STATE
GCN4-LEUCINE ZIPPER CORE MUTANT ASN16GLN IN THE TRIMERIC STATE
LEUCINE ZIPPER MONOMER (NMR, 20 STRUCTURES)
GCN4 BASIC DOMAIN, LEUCINE ZIPPER COMPLEXED WITH ATF/CREB SITE DEOXYRIBONUCLEIC ACID
GCN4 LEUCINE ZIPPER
PDBE
Y
PDBE
2003-09-15
REL
BASED ON SEQUENCE FROM SACCHAROMYCES CEREVISIAE (BAKER'S YEAST)
4932
BAKER'S YEAST
SACCHAROMYCES CEREVISIAE
sample
ENGINEERED RESIDUE LEU 274 ALA, CHAINS A AND B
n
1
-1
A
ARG
1
n
2
ARG
1
A
MET
2
n
3
MET
2
A
LYS
3
n
4
LYS
3
A
GLN
4
n
5
GLN
4
A
ILE
5
n
6
ILE
5
A
GLU
6
n
7
GLU
6
A
ASP
7
n
8
ASP
7
A
LYS
8
n
9
LYS
8
A
LEU
9
n
10
LEU
9
A
GLU
10
n
11
GLU
10
A
GLU
11
n
12
GLU
11
A
ILE
12
n
13
ILE
12
A
LEU
13
n
14
LEU
13
A
SER
14
n
15
SER
14
A
LYS
15
n
16
LYS
15
A
LEU
16
n
17
LEU
16
A
TYR
17
n
18
TYR
17
A
HIS
18
n
19
HIS
18
A
ILE
19
n
20
ILE
19
A
GLU
20
n
21
GLU
20
A
ASN
21
n
22
ASN
21
A
GLU
22
n
23
GLU
22
A
LEU
23
n
24
LEU
23
A
ALA
24
n
25
ALA
24
A
ARG
25
n
26
ARG
25
A
ALA
26
n
27
ALA
26
A
LYS
27
n
28
LYS
27
A
LYS
28
n
29
LYS
28
A
LEU
29
n
30
LEU
29
A
LEU
30
n
31
LEU
30
A
GLY
31
n
32
GLY
31
A
GLU
32
n
33
GLU
32
A
n
34
33
A
n
1
-1
B
ARG
1
n
2
ARG
1
B
MET
2
n
3
MET
2
B
LYS
3
n
4
LYS
3
B
GLN
4
n
5
GLN
4
B
ILE
5
n
6
ILE
5
B
GLU
6
n
7
GLU
6
B
ASP
7
n
8
ASP
7
B
LYS
8
n
9
LYS
8
B
LEU
9
n
10
LEU
9
B
GLU
10
n
11
GLU
10
B
GLU
11
n
12
GLU
11
B
ILE
12
n
13
ILE
12
B
LEU
13
n
14
LEU
13
B
SER
14
n
15
SER
14
B
LYS
15
n
16
LYS
15
B
LEU
16
n
17
LEU
16
B
TYR
17
n
18
TYR
17
B
HIS
18
n
19
HIS
18
B
ILE
19
n
20
ILE
19
B
GLU
20
n
21
GLU
20
B
ASN
21
n
22
ASN
21
B
GLU
22
n
23
GLU
22
B
LEU
23
n
24
LEU
23
B
ALA
24
n
25
ALA
24
B
ARG
25
n
26
ARG
25
B
ALA
26
n
27
ALA
26
B
LYS
27
n
28
LYS
27
B
LYS
28
n
29
LYS
28
B
LEU
29
n
30
LEU
29
B
LEU
30
n
31
LEU
30
B
GLY
31
n
32
GLY
31
B
GLU
32
n
33
GLU
32
B
n
34
33
B
author_and_software_defined_assembly
PQS
4
tetrameric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
-1.0000000000
0.0000000000
19_655
-x+7/4,-z+3/4,-y+3/4
crystal symmetry operation
138.7137500000
59.4487500000
59.4487500000
1
A
CA
GLU
32
A
CA
GLU
33
1
Y
1
A
C
GLU
32
A
C
GLU
33
1
Y
1
A
O
GLU
32
A
O
GLU
33
1
Y
1
A
CB
GLU
32
A
CB
GLU
33
1
Y
1
A
CG
GLU
32
A
CG
GLU
33
1
Y
1
A
CD
GLU
32
A
CD
GLU
33
1
Y
1
A
OE1
GLU
32
A
OE1
GLU
33
1
Y
1
A
OE2
GLU
32
A
OE2
GLU
33
1
Y
1
B
CA
GLU
32
B
CA
GLU
33
1
Y
1
B
C
GLU
32
B
C
GLU
33
1
Y
1
B
O
GLU
32
B
O
GLU
33
1
Y
1
B
CB
GLU
32
B
CB
GLU
33
1
Y
1
B
CG
GLU
32
B
CG
GLU
33
1
Y
1
B
CD
GLU
32
B
CD
GLU
33
1
Y
1
B
OE1
GLU
32
B
OE1
GLU
33
1
Y
1
B
OE2
GLU
32
B
OE2
GLU
33
1
Y
1
A
ACE
-1
A
ACE
1
1
Y
1
A
ARG
33
A
ARG
34
1
Y
1
B
ACE
-1
B
ACE
1
1
Y
1
B
ARG
33
B
ARG
34
1
Y
1
11.02
1.70
111.00
122.02
A
A
A
CB
CG
CD1
LEU
LEU
LEU
13
13
13
N
1
-12.52
1.60
122.70
110.18
A
A
A
O
C
N
GLY
GLY
GLU
31
31
32
Y
1
6.47
0.50
120.30
126.77
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
1
1
1
N
1
-9.98
1.20
123.30
113.32
B
B
B
OE1
CD
OE2
GLU
GLU
GLU
22
22
22
N
1
11.18
1.70
111.00
122.18
B
B
B
CB
CG
CD2
LEU
LEU
LEU
29
29
29
N
1
A
A
CA
CB
SER
SER
14
14
0.094
0.015
1.525
1.619
N
1
A
A
CB
OG
SER
SER
14
14
-0.083
0.013
1.418
1.335
N
1
A
A
N
CA
LYS
LYS
15
15
-0.151
0.020
1.459
1.308
N
1
A
A
CD1
CE1
TYR
TYR
17
17
-0.101
0.015
1.389
1.288
N
1
A
A
CE1
CZ
TYR
TYR
17
17
-0.128
0.013
1.381
1.253
N
1
A
A
CD
OE2
GLU
GLU
20
20
0.085
0.011
1.252
1.337
N
1
A
A
CD
OE1
GLU
GLU
22
22
0.172
0.011
1.252
1.424
N
1
A
A
CD
OE2
GLU
GLU
22
22
0.107
0.011
1.252
1.359
N
1
A
A
CE
NZ
LYS
LYS
28
28
0.191
0.025
1.486
1.677
N
1
B
B
NE
CZ
ARG
ARG
1
1
0.091
0.013
1.326
1.417
N
1
B
B
CG
CD
GLU
GLU
6
6
0.128
0.015
1.515
1.643
N
1
B
B
CD
OE1
GLU
GLU
6
6
0.132
0.011
1.252
1.384
N
1
B
B
CD
OE2
GLU
GLU
6
6
0.095
0.011
1.252
1.347
N
1
B
B
CD
CE
LYS
LYS
8
8
0.208
0.025
1.508
1.716
N
1
B
B
CE
NZ
LYS
LYS
8
8
0.174
0.025
1.486
1.660
N
1
B
B
CD
OE1
GLU
GLU
11
11
0.090
0.011
1.252
1.342
N
1
B
B
CB
CG2
ILE
ILE
12
12
-0.226
0.031
1.524
1.298
N
1
B
B
CD
OE1
GLU
GLU
20
20
0.079
0.011
1.252
1.331
N
1
B
B
CD
OE2
GLU
GLU
20
20
-0.082
0.011
1.252
1.170
N
1
B
B
CG
CD
LYS
LYS
28
28
0.251
0.034
1.520
1.771
N
39.946
0.29885
0.22603
0.22883
2.40
55.90
158
3488
4.3
99.83
7.078
0.167
RANDOM
1
THROUGHOUT
MOLECULAR REPLACEMENT
0.335
0.281
2.40
55.90
0
520
0
0
520
2.214
35.448
1UO0
3657
2.000
0.12300
1
5.8000
12.300
100.0
refinement
REFMAC
data reduction
CrystalClear
(MSC/RIGAKU)
data scaling
SCALA
phasing
MOLREP
GENERAL CONTROL PROTEIN GCN4
Structure Based Engineering of Internal Molecular Surfaces Of Four Helix Bundles
1
N
N
1
N
N
A
ARG
1
A
ARG
2
HELX_P
A
LEU
30
A
LEU
31
1
1
30
B
ARG
1
B
ARG
2
HELX_P
B
LEU
30
B
LEU
31
1
2
30
FOUR HELIX BUNDLE
FOUR HELIX BUNDLE, CAVITY
1UO0
PDB
1
1UO0
GCN4_YEAST
UNP
1
P03069
-1
-1
1UO0
-1
-1
1UO0
A
1
1
1
249
281
1UO0
1
33
P03069
A
2
2
34
-1
-1
1UO0
-1
-1
1UO0
B
1
1
1
249
281
1UO0
1
33
P03069
B
2
2
34
1
LEU
conflict
ILE
5
1UO0
A
P03069
UNP
253
6
1
VAL
conflict
LEU
9
1UO0
A
P03069
UNP
257
10
1
LEU
conflict
ILE
12
1UO0
A
P03069
UNP
260
13
1
ASN
conflict
LEU
16
1UO0
A
P03069
UNP
264
17
1
LEU
conflict
ILE
19
1UO0
A
P03069
UNP
267
20
1
VAL
conflict
LEU
23
1UO0
A
P03069
UNP
271
24
1
LEU
engineered mutation
ALA
26
1UO0
A
P03069
UNP
274
27
1
VAL
conflict
LEU
30
1UO0
A
P03069
UNP
278
31
3
LEU
conflict
ILE
5
1UO0
B
P03069
UNP
253
6
3
VAL
conflict
LEU
9
1UO0
B
P03069
UNP
257
10
3
LEU
conflict
ILE
12
1UO0
B
P03069
UNP
260
13
3
ASN
conflict
LEU
16
1UO0
B
P03069
UNP
264
17
3
LEU
conflict
ILE
19
1UO0
B
P03069
UNP
267
20
3
VAL
conflict
LEU
23
1UO0
B
P03069
UNP
271
24
3
LEU
engineered mutation
ALA
26
1UO0
B
P03069
UNP
274
27
3
VAL
conflict
LEU
30
1UO0
B
P03069
UNP
278
31
213
P 41 3 2